MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

A Trial of a Multi-component Individualized Telephone-based Support Intervention for Adult-child Caregivers Caring for Parents With Dementia

Not Applicable
Withdrawn
Conditions
Dementia
Interventions
Other: Usual Care
Behavioral: HEART
First Posted Date
2017-12-19
Last Posted Date
2021-04-20
Lead Sponsor
Yale University
Registration Number
NCT03378050

Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone

Not Applicable
Completed
Conditions
Multiple Myeloma
Interventions
Procedure: Guided Lesion Biopsies
Procedure: Standard Lesion Biopsies
First Posted Date
2017-12-18
Last Posted Date
2022-02-24
Lead Sponsor
Yale University
Target Recruit Count
28
Registration Number
NCT03375567
Locations
🇺🇸

Yale Cancer Center, New Haven, Connecticut, United States

Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention

Not Applicable
Completed
Conditions
Drug Use Disorders
Interventions
Behavioral: TAU plus Control Tasks
Behavioral: TAU plus Cognitive Remediation Program
First Posted Date
2017-12-14
Last Posted Date
2021-01-08
Lead Sponsor
Yale University
Target Recruit Count
46
Registration Number
NCT03373240
Locations
🇺🇸

Substance Abuse Treatment Center (SATU), New Haven, Connecticut, United States

Home vs. Office Foley Catheter Removal in Women With Voiding Difficulty Following Pelvic Reconstructive Surgery

Not Applicable
Completed
Conditions
Voiding Disorders
Interventions
Procedure: Foley catheter removal
First Posted Date
2017-12-14
Last Posted Date
2022-08-29
Lead Sponsor
Yale University
Target Recruit Count
78
Registration Number
NCT03373773
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)

Not Applicable
Terminated
Conditions
Infertility
Interventions
Procedure: Trophectoderm biopsy
Procedure: Cryopreservation
Procedure: Embryo Transfer
First Posted Date
2017-12-13
Last Posted Date
2022-10-03
Lead Sponsor
Yale University
Target Recruit Count
32
Registration Number
NCT03371745
Locations
🇺🇸

University of California San Francisco, San Francisco, California, United States

🇺🇸

University of Oklahoma, Oklahoma City, Oklahoma, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Translating Neuroprediction Into Precision Medicine Via Brain Priming

Phase 2
Terminated
Conditions
Autism Spectrum Disorder
Interventions
Behavioral: Pivotal Response Treatment
Drug: Placebo
First Posted Date
2017-12-12
Last Posted Date
2022-08-09
Lead Sponsor
Yale University
Target Recruit Count
5
Registration Number
NCT03370510
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial

Phase 1
Completed
Conditions
Depressive Disorder, Major
Post Traumatic Stress Disorder
Bipolar Disorder
Interventions
First Posted Date
2017-12-08
Last Posted Date
2025-02-07
Lead Sponsor
Yale University
Target Recruit Count
13
Registration Number
NCT03367533
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis

Phase 2
Terminated
Conditions
Cholangitis, Sclerosing
Interventions
First Posted Date
2017-12-02
Last Posted Date
2021-08-09
Lead Sponsor
Yale University
Target Recruit Count
2
Registration Number
NCT03359174
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Phase 1
Completed
Conditions
Obsessive-Compulsive Disorder
Interventions
First Posted Date
2017-11-29
Last Posted Date
2024-11-20
Lead Sponsor
Yale University
Target Recruit Count
31
Registration Number
NCT03356483
Locations
🇺🇸

Connecticut Mental Health Center, New Haven, Connecticut, United States

Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes

Early Phase 1
Completed
Conditions
Hyperglycaemia (Diabetic)
Interventions
Drug: Placebo oral capsule
First Posted Date
2017-11-29
Last Posted Date
2021-01-22
Lead Sponsor
Yale University
Target Recruit Count
21
Registration Number
NCT03356457
Locations
🇺🇸

Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath